# Dose-response Study of Arginine Supplementation in Severe Sepsis

> **NCT01775020** · EARLY_PHASE1 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DIETARY_SUPPLEMENT:** L-arginine

## Key facts

- **NCT ID:** NCT01775020
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2004-05
- **Final completion:** 2012-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01775020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01775020, "Dose-response Study of Arginine Supplementation in Severe Sepsis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01775020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*